Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 2

1(33.3%)

3Total

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04629053Recruiting

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia

Role: collaborator

NCT05972772Phase 2Recruiting

Rickettsia Clearance Study

Role: lead

NCT04478578Recruiting

Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia

Role: collaborator

NCT05239104Completed

Laos Out-Of-Pocket Costs: an Observational Study on the Impact of Severe Childhood Illness on the Health, Wealth and Wellbeing of Household Members in Laos

Role: collaborator

NCT04914793Not ApplicableCompleted

Lao Anti-Microbial Prescribing Guidelines Mobile Phone Application (LAMPA)

Role: lead

NCT04285021Completed

Prediction of Disease Severity in Young Children Presenting With Acute Febrile Illness in Resource-limited Settings

Role: collaborator

NCT03217851Completed

Prevalence Survey of Antimalarial Drug Resistance Markers

Role: collaborator

NCT02876367Completed

The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents

Role: collaborator

NCT01872702Not ApplicableCompleted

Targeted Chemo-elimination (TCE) of Malaria

Role: collaborator

NCT03578133Completed

Causes of Pneumonia in Yangon

Role: collaborator

All 10 trials loaded